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Study Patient Number Months from 
Surgery to Survey* 
Major LARS Minor LARS No LARS 
Total % Response 
Emmertsen 478 
  
92.8% Mean 55.5 40% 25% 35% 
Juul et al. 579   80% Median 58.8  47% 23% 30% 
Bondeven et 
al 
125  100% - 
retrospective 
Median18 35% 24% 35% 
Hain  135 87% Median 43  23% 50% 31% 
Bregendahl 1087  90.1% Median 54  41% 23.5%% 35.5% 
Juul et al. 
  
1061  76% Mean 67.2   52% 19% 29% 
Luca et al 23  
  
100%  12 23.8% 19% 57.1% 
Hughes  85  80% Median 8  56% 18% 26% 
Carillo et al. 195   70% Median 37 47% 18.9%)  34.1% 
Ekkarat et al.  
  
129  expected 100% Median 38 17.8% 17% 65.4% 
Sturiale  110  84.5% Median 164.4 20.5% 27% 52.5% 
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Study Significant Risk Factor  Not Significant Risk Factor Not Discussed 
Emmertsen 
2012, 
Denmark 
- Radiotherapy 
- Anastomotic height < 5cm from anal 
verge) 
  
  
- Age  
- Gender 
- Anastomotic leak 
- Timing of reversal 
- Anastomotic type 
Juul et al. 
2015, 
Denmark + UK 
- Neoadjuvant radiotherapy 
- Anastomotic height  < 5cm 
  
  
- Age  
- Gender 
- Anastomotic leak 
- Timing of reversal 
- Anastomosis type 
Bondeven et 
al 
2015, 
Denmark 
- Long course Neoadjuvant 
chemoradiation 
- Anastomotic height < 4 cm 
- Age 
- Gender 
- Anastomosis type (end-end vs end-
side) 
- Anastomotic leak 
(exclusion) 
- Timing of reversal 
Hain 
2016, France  
- Symptomatic anastomotic leak 
- Anastomosis type (hand-sewn 
coloanal or end-side = higher risk) 
- Long course radiotherapy 
- Anastomotic height 
(‘intersphincteric’) 
  
- Age 
- Gender 
  
  
  
- Timing of reversal  
Bregendahl 
2013, 
Denmark 
- Neoadjuvant radiotherapy 
- Anastomotic height (TME for <10cm) 
- Age 
- Anastomotic type (colonic pouch vs 
straight to end or side to end) 
- gender 
-anastomotic leak 
- Timing of reversal 
Juul et al. 
2014, 
multicentre 
international  
  
No statistical analysis discussed 
- Radiotherapy: 64% Major LARS, 18.3% minor, 17% no LARS 
- Anastomotic height: Major LARS 9cm, Minor 9.6cm, no LARS 10.6cm 
- Mean age (Major LARS: 66.4, Minor LARS: 68.9, no LARS: 70.2) 
- Gender: Major LARS: males 56%, females: 44% 
- Anastomotic leak 
- timing of reversal 
- Anastomotic type 
Luca et al 
2016, Italy 
  
  
- Radiotherapy: long course 
neoadjuvant 
- Anastomotic height 
- Age 
- Gender 
*These was not displayed in the data 
- Anastomotic leak 
- Timing of reversal 
- All patients: hand-
sewn coloanal - 
standardised 
  
Hughes  
2017, UK 
- Timing of reversal: ileostomy closure 
> 1 year increased risk of major LARS 
- Neoadjuvant radiation (20 fold 
increased risk major LARS) 
- Age 
- Gender 
- Anastomotic leak 
- Anastomotic height 
  
- Anastomotic type 
Carillo et al. 
2016, Spain 
- Radiotherapy: long course 
- Anastomotic height*: TME > PME 
(TME for lower and middle rectal Ca, 
PME for upper rectal Ca) 
 - Diverting stoma > no stoma  
- Lack of reservoir (colonic pouch/ 
coloplasty) = greater major LARS 
- Age 
- Gender 
- Anastomotic leak (reported as 
‘anastomotic complications’) 
  
  
Ekkarat et al.  
2016, Thailand 
- Adjuvant radiotherapy 
- Anastomotic height <5cm 
- Diverting stoma>no stoma 
- Age 
- Gender 
- Anastomosis type 
- Anastomotic leak 
  
Sturiale  
2016, Italy 
- Age 
 - Timing to reversal of ileostomy: 
median Major LARS: 5.4 months, 
minor: 3.3 months, no LARS: 2.6 
months  
- Neoadjuvant radiotherapy 
- Anastomotic height <5cm 
- Gender 
- Anastomotic leak 
  
- Anastomotic type 
  
Background 
 Low anterior resection + TME is the 
preferred procedure for mid and low rectal 
cancers.1  
 Low Anterior Resection Syndrome (LARS): 
Incontinence (faeces +/- flatus), urgency, 
diarrhoea, frequency and clustering of 
bowel motions.2,3  
 Bowel adaptation occurs by 18 months.4   
 Estimated prevalence of LARS 19-52%.6   
 Variability due to non-specific data 
collection tools that do not take QOL into 
consideration. 
 ‘LARS score’ - validated scoring system 
specific for LAR taking into account impact 
on overall quality of life.3   
 Aim of this review was to analyze published 
data on the prevalence of LARS, from 
studies utilizing the LARS score.  Risk 
factors also assessed. 
Methods 
• Pubmed, Ovid Medline, Cochrane 
• MeSH: “Low anterior resection 
syndrome”, “Anterior Resection 
syndrome”, “Prevalence”, “Incidence”, 
“bowel function”, “Quality of life” and 
“Low anterior resection syndrome score” 
• Screened by title and abstract  
• Inclusion criteria: English language studies 
using LARS score assessing prevalence 
and causative factors. 
• Articles scored using QUADAS2 tool – 11 
good quality studies found 
• Prevalence of major, minor and no LARS, 
patient variables and treatment variables 
recorded 
• All studies, with the exception of 2,1,14 had 
a mean or median follow >or= 18 months. 
•   
Statistical Analysis 
• Meta-analysis using a quality-effects model (factoring the QUADAS2 scores) conducted using MetaXL 
• Pooled prevalence figure was calculated with 95% CI. 
• Meta-analysis conducted with prevalence estimates that had been transformed using the double arcsine method. This method avoids variance moving towards zero 
as a result of estimate of the study tending towards 0% or 100%, resulting in over estimation of weight in meta-analysis. 
Results 
• Prevalence of Major LARS ranged from 17.8%-56%, 
• Meta-analysis prevalence using the quality effect model was 
41% (95% CI 34 -48), I2=91%, p<0.001 
• The study with the lowest rate of major LARS excluded 
patients who had undergone neoadjuvant therapy and had a 
larger percentage of patients with tumours in the upper rectum 
(>40%) . 
• Hughes et al.1 had highest rate of LARS (56%). Potentially 
because they included patients with restoration of intestinal 
continuity of only 12 weeks. Patients <1yr following surgery 
had a mean LARS of 35.5 compared to 27.9 in >4years. 
• Neoadjuvant or adjuvant radiotherapy was the most 
consistently assessed variable affecting major LARS 
(statistical significance in studies).1,3,6-9,12-13  
• Tumour height (anastomotic level): 6 of the 11 studies 
identified a statistically significant association.3,7-9,12-13   
• Four studies looked at the presence of an ileostomy and 
duration prior to reversal, all of which found an increased risk 
of major LARS with ileostomy formation and/or prolonged 
duration.1,6,12-13  
• Having a complication of an anastomosis was found to be 
associated with increased risk of developing major LARS and 
in one study this association was significant.8  
• None of these studies found any significant association with 
gender and LARS. 
• Age was statistically significantly in only one study.13   
Discussion 
• Radiation has also been found to have negative effects on 
function in LAR patients with greater numbers of incontinent 
episodes and decreased rectal sensation.15 Reducing the dose 
leads to improvement in sphincter function.16   
• Increased rates of Major LARS in patients with a diverting 
ileostomy expected to be due to underlying reason for the 
ileostomy. 
• Temporary ileostomy more common in lower resections – a 
recognized risk for LARS 
• anastomotic leaks treated with ileostomy for a prolonged 
period – could the increased rate of LARS be due to 
prolonged ileostomy  
• Although colonic adaption over a period of about 12months 
may improve bowel function, we confirm that a significant 
population of patients continue to suffer into the mid and long 
term. 
• Impaired anal sphincter function has been identified in patients 
following LAR and has been shown to be associated with 
poorer functional outcome.2,6,18 
• resultant impairment of the anal sphincter could be due to 
both direct injury to the anal sphincter as well as damage to it 
innervation with pelvic dissection of the rectum 
• Altered intestinal motility due to disruption of the 
parasympathetic innervation of the bowel has been suggested 
to play a role in the development of LARS 
• LARS must be taken into appropriate consideration in the 
management of rectal cancer, although oncological 
considerations need to be prioritized.   
• Improved selectivity for radiotherapy may result in less 
prevalence of post-operative morbidity 
• PME rather than TME  as the oncological outcomes are 
equivalent and functional outcomes appear to be superior. 
• Pre-operative counselling and education about functional 
outcomes should detail LARS risk. 
• Therapies such as biofeedback, sacral nerve modulation and 
rectal irrigation are showing promise in improving anorectal 
function and quality of life post LAR. 
  
Meta-analysis Major LARS Minor LARS No LARS 
Prevalence 41% 24% 35% 
Records identified through 
databases (n=278) 
Duplicates removed 
(n=158) 
Records screened (n=158) 
Full text articles 
assessed for 
eligibility (n=40) 
Records excluded 
(n=118) 
Articles excluded 
as not using LARS 
data collection tool 
(n=29) 
Studies included in qualitative synthesis 
(QUADS2 tool) (n=11) 
